> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Panel to Discuss Rebiotix BLA
- URL: https://www.fdaweb.com/panel-to-discuss-rebiotix-bla/
- Published: 2022-08-08T12:00:00.000Z
- Updated: 2026-09-14T17:55:02.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5152458

*Federal Register* notice: FDA has announced a 9/22 Vaccines and Related Biological Products Advisory Committee meeting. Panel members are scheduled to discuss a BLA from Rebiotix for Rebyota (fecal microbiota, live) for reducing the recurrence of *Clostridioides difficile* infection in adults following antibiotic treatment. To view the notice, click [here](https://public-inspection.federalregister.gov/2022-17059.pdf?ref=fdaweb.com).